Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case–control study
N. Lynn Henry(University of Michigan), Justin Stebbing(Anglia Ruskin University), Anne Nguyen(Indiana University School of Medicine), Anna Maria Storniolo(Indiana University Health), Vered Stearns(Johns Hopkins University), Daniel F. Hayes(University of Michigan–Ann Arbor), Jonathan Waxman, David A. Flockhart(Indiana University – Purdue University Indianapolis), L Li(Indiana University Indianapolis), Dmitri Pchejetski(University of East Anglia), P. Charles(Lung Institute), Roger A’Hern
Cited by 46
Related Papers
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k